Theriva™ biologics to participate in the a.g.p. virtual healthcare conference

Rockville, md., may 14, 2024 (globe newswire) -- theriva™ biologics (nyse american: tovx), a diversified clinical-stage company developing therapeutics designed to treat cancer and related diseases in areas of high unmet need, today announced that company's management will provide a corporate update and participate in a fireside chat at the a.g.p. 2024 virtual healthcare conference.
TOVX Ratings Summary
TOVX Quant Ranking